A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Business Account Executive - Rare Disease

Field SalesConfirmed live in the last 24 hours
Full-timeRemote in USA$160.7k - $217.3k

About the Job

Requirements

  • A bachelor's degree is required.
  • At least five years of demonstrated success in biotech, specialty pharmaceuticals, or medical devices.
  • Thorough understanding of site-of-care identification, development, and education.
  • Strong examples of an applied entrepreneurial mindset, business analytics, and data analysis.
  • Experience driving, leading, and delivering territory-level cross-functional business planning.
  • Familiarity with the relevant legal and regulatory environment in the biotech and pharmaceutical industry.
  • Strong communication and listening skills.
  • Ability to manage complex individualized cases in a compliant manner.
  • A valid driver's license is required.
  • Must live in the assigned territory.

Responsibilities

  • Drive patient identification through appropriate healthcare professional-driven strategies, market development, and increased brand awareness by building and executing a territory strategy and account plan; continuously assess opportunities within markets and accounts for successful launches.
  • Prioritize and manage time, activities, and resources to optimize access to academic and community healthcare professionals.
  • Build and maintain relationships with healthcare professionals and office staff through planning, leveraging insights, conducting post-call analysis, and refining tactics based on opportunities.
  • Proactively build effective working relationships with internal and external stakeholders and drive agreement and decisions from multiple stakeholders, adapting communication to different stakeholders.
  • Collaborate with commercial departments, including patient services and field reimbursement, to ensure access at sites of care and that medication-administration logistics are in place.
  • Collaborate with key accounts and physicians to build individual account plans that drive patient identification through market development and physician education, achieve sales goals, and maximize sales results while maintaining relationships.
  • Execute speaker programs, local sponsorships, displays, and exhibits in and out of the office across academic institutions, physician offices, infusion centers, and alternate site locations.
  • Routinely report territory-level market dynamics and trends, including prescriber opinion and competitive activity, to the Regional Business Director as required.
  • Cover Upstate New York and Central Pennsylvania.
  • Travel overnight as required, including travel to Boston, congresses, and large geographical territories.

Desired Qualifications

  • Experience, success, and relationships in rare disease, gastroenterology, hepatology, neurology, hematology/oncology, pediatric and adult nephrology, and/or urology.
  • Understanding of Buy & Bill and experience working with HUB patient services.
  • Experience supporting biologic therapy administered by designated healthcare professionals.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs